AI Summary
Advances in precision medicine are transforming cancer treatment by focusing on disease biology. This approach is leading to clinical progress and drug approvals. Additionally, the impact of the host in tumor response and prognosis is being recognized. Contemporary oncology care plans encompass both biological and non-biological factors.
Advances in the field of precision medicine are revolutionizing cancer treatment.1 Agnostic treatment approaches that focus on disease biology are being increasingly tested2 leading to clinical progress and drug approvals.3,4 In addition, consistent data is highlighting the impact of the host in tumor response and prognosis5,6. Therefore, contemporary oncology care plans go way beyond the primary anatomic tumor location and encompass cancer in its entire individual complexity including both biological (intrinsic to the patient or to the disease and its microenvironment) and non-biological factors (socioeconomic, cultural, environmental, behavioral).